Filing Flows › Vir Biotechnology (VIR) › How it makes money
How Vir Biotechnology (VIR) makes money
Vir Biotechnology (VIR) made $239M of revenue in the second quarter 2026 (Q2 2026). License and collaboration revenue brought in $239M (100%); Grant revenue brought in $11K (0%). Of every dollar of revenue, 31¢ was left as operating profit, 34¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| License and collaboration revenue | $239M | 100.0% | — | — |
| Grant revenue | $11K | 0.0% | — | -94% |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $239M | 100.0% |
| Operating profit | $73.5M | 30.7% |
| Income tax | $179K | 0.1% |
| Net earnings | $80.1M | 33.5% |
| Operating cash flow | $123M | 51.6% |
| Free cash flow | $123M | 51.6% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $239M | 197× |
| Q4 2025 | $64.1M | +418% |
| Q3 2025 | $240K | -90% |
| Q2 2025 | $1.2M | -60% |
| Q1 2025 | $3.0M | -95% |
From Vir Biotechnology's 10-Q filed Aug 5, 2026 (on EDGAR).
Questions
How does Vir Biotechnology make money?
Vir Biotechnology (VIR) made $239M of revenue in the second quarter 2026 (Q2 2026). License and collaboration revenue brought in $239M (100%); Grant revenue brought in $11K (0%). Of every dollar of revenue, 31¢ was left as operating profit, 34¢ was left as net earnings.
What is Vir Biotechnology's biggest business?
License and collaboration revenue: $239M in the second quarter 2026, 100% of revenue.
What is Vir Biotechnology's profit margin?
Net earnings were $80.1M, 33.5% of revenue, in the second quarter 2026; the operating margin was 30.7%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.